Psychedelics Filament Health ships psilocybin drug to Australia, first country legally prescribing psychedelics The shipment was received by the medical cannabis company Little Green Pharma and its psychedelics subsidiary Rowan DunneJanuary 17, 2024
Psychedelics PharmAla Biotech ships first batch of MDMA and psilocybin to be used as medicines in Australia This is the first shipment that will be used specifically under the country's Authorized Prescriber Scheme enacted in July Rowan DunneNovember 7, 2023
Psychedelics PharmAla Biotech lists on the OTCQB middle-tier venture market The MDMA producer is now trading under the symbol PMBHF, which is intended to attract more investors in the U.S. Rowan DunneSeptember 6, 2023
News PharmAla Biotech secures first purchase order for GMP LaNeo MDMA in Australia Patients in Australia can use psilocybin and MDMA as of July 1 Natalia Buendia CalvilloJuly 5, 2023
Psychedelics PharmAla Biotech first to get Special Access Program authorization for its MDMA Health Canada granted PharmAla approval to provide its LaNeo product to a physician that will facilitate MDMA-assisted therapy Rowan DunneMay 16, 2023
Psychedelics Incannex orders psilocybin and MDMA from PharmAla Biotech Incannex plans to open a series of psychedelics clinics in Australia and use PharmAla's products Rowan DunneApril 25, 2023
Psychedelics PharmAla Biotech signs agreement to sell clinical-grade MDMA in Australia Companies are running more MDMA and psilocybin trials after the Australian drug regulation changes Natalia Buendia CalvilloFebruary 14, 2023
Psychedelics Psyched Wellness formulates first commercial Amanita muscaria extract The cartoon-like toadstool is psychoactive, has medicinal properties and lives in a symbiotic relationship with certain trees Rowan DunneFebruary 9, 2023
Psychedelics PharmAla Biotech gets Health Canada approval to export large MDMA shipment to the U.K. The company believes this to be the largest shipment of MDMA the government department has ever approved Rowan DunneJanuary 24, 2023
Canada PharmAla and Mindset enter psilocybin distribution agreement PharmAla will have exclusive rights to resell Mindset's cGMP psilocybin to designated researchers Rowan DunneNovember 16, 2022